It's going to be easy
doi:10.1016/j.hrthm.2006.12.006 61
In this post, well explore what employers are doing, the pros and cons of covering GLP-1s, and what the future may hold
Conversely, in another phase 2b study involving patients with T2DM, tirzepatide showed significantly better efficacy in glucose control and weight loss compared to both placebo and dulaglutide, with an acceptable safety and tolerability profile (111)
Further, we think second-quarter topics like ACA procedure headwinds, China competition, law of large numbers catching up to growth, and initiatives focused on lowering prices could all weigh on sentiment as they introduce some uncertainty around the P&Lcollectively, these might limit share upside in the next couple of quarters." "On balance, the quarter itself looked fine, though the combination of softer U.S
[12] [13] This mechanism may partially explain the metabolic improvements observed following bariatric surgery, where altered bile acid circulation enhances incretin responses